ENMC Encore Medical

AUSTIN, Texas, Feb. 10 /PRNewswire-FirstCall/ -- Encore Medical Corporation (NASDAQ:ENMC) announced today that the Company will release fiscal 2005 fourth quarter and year end financial results prior to the opening of trading on Monday, February 27, 2006. The Company will then host a conference call beginning at 10 am Eastern Time to discuss the results of operations and recent business developments. A live webcast of the conference can be accessed from Encore's website http://www.encoremed.com/ . If you are unable to participate during the live webcast, an audio archive will be available shortly after the call and will be accessible from Encore's website for approximately 30 days. A telephonic replay of the conference call will also be available for one week after the call by dialing (domestic) (800) 642-1687 or (international) (706) 645-9291 and requesting conference ID #5268525. Encore Medical Corporation is a diversified orthopedic device company that develops, manufactures and distributes a comprehensive range of high quality orthopedic devices, including surgical implants, sports medicine equipment and products for orthopedic rehabilitation, pain management and physical therapy. Based in Austin, Texas, Encore's products are used by orthopedic surgeons, physicians, therapists, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events and sports-related injuries. Encore's non-invasive medical devices and related accessories are primarily used by patients for at-home physical therapy. Encore's Surgical Implant Division offers a comprehensive suite of reconstructive joint products and spinal implants. Through its Orthopedic Rehabilitation Division, Encore is a leading manufacturer and distributor of orthopedic rehabilitation equipment in the United States. For more information, visit http://www.encoremed.com/ . This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning expectations for the timing of the closing of pending acquisitions. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the fulfillment of all requisite closing conditions could affect the timing of this acquisition. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in the Business section of Encore Medical's Annual Report on Form 10- K for the year ended December 31, 2004 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. Contact: Davis Henley, Vice President - Business Development (512) 832-9500 DATASOURCE: Encore Medical Corporation CONTACT: Davis Henley, Vice President - Business Development of Encore Medical Corporation, +1-512-832-9500, or Web site: http://www.encoremed.com/

Copyright